Results 61 to 70 of about 5,793,459 (255)

Age-specific hospital-based maternal mortality rates, 2006–2015.

, 2019
Age-specific hospital-based maternal mortality rates, 2006–2015.
Susan F. Rumisha (650281), Irene R. Mremi (5916842), Emanuel P. Lyimo (5916836), Veneranda M. Bwana (5217281), Leonard E. G. Mboera (527334)   +4 more
core   +1 more source

The effect of delaying childbirth on primary cesarean section rates [PDF]

, 2008
<p><b>Background:</b> The relationship between population trends in delaying childbirth and rising rates of primary cesarean delivery is unclear.
Yolande Cordeaux, Fleming Michael, Hannah Missfelder-Lobos, Missfelder-Lobos, Hannah, Jill P Pell, Smith, Gordon C S, Missfelder-Lobos Hannah, Pell, Jill P, Charnock-Jones, D Stephen, Fleming, M., Michael Fleming, Dharmintra Pasupathy, Smith Gordon C. S, White, Ian R, White Ian R, Pasupathy, Dharmintra, Fleming, Michael, Cordeaux Yolande, Gordon C S Smith, White, I.R., Pasupathy, D., Cordeaux, Y., Pell, J., Pasupathy Dharmintra, Charnock-Jones, D.S., Pell Jill P, Smith, G.C.S., Cordeaux, Yolande, D. Stephen Charnock-Jones, Gordon C. S Smith, D Stephen Charnock-Jones, Ian R White, Charnock-Jones D. Stephen, Missfelder-Lobos, M.   +33 more
core   +2 more sources

Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy. Methods The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean ...
Marika Pane, Anna Capasso, Chiara Arpaia, Adele D’Amico, Emilio Albamonte, Federica Trucco, Maria Sframeli, Riccardo Masson, Francesca Magri, Luca Bello, Romina Venditti, Claudia Dosi, Michela Catteruccia, Michele Tosi, Claudio Bruno, Sonia Messina, Giacomo Comi, Elena Pegoraro, Valeria A. Sansone, Eugenio Mercuri   +19 more
wiley   +1 more source

Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach, Sandra Donkervoort, Carola Hedberg‐Oldfors, Giovanni Baranello, Dimah Saade, Precilla D'Souza, Ruchee Patel, Eva Michael, A. Reghan Foley, Diana Bharucha‐Goebel, S. Jin Haugland, Meghan McAnally, Omer Abdul Hamid, Katherine Chao, Ellen F. Macnamara, Alan H. Beggs, Anna Sarkozy, Juliane Mueller, Steven A. Moore, Richard S. Finkel, Cynthia J. Tifft, Francesco Muntoni, Anders Oldfors, Carsten G. Bönnemann   +23 more
wiley   +1 more source

Experimental and comparative analyses of maternal age and senescence [PDF]

, 2019
Senescence is often described as an age-related physiological deterioration accompanied with declining fertility and increasing mortality, and it is believed to be the result of declining forces of natural selection.
Ivimey-Cook, Edward Richard
core  

Correlations between Maternal Age, Education, and Knowledge on the Compliance of COVID-19 Vaccine Uptake in Children Aged 6 – 11 Years

, 2022
Background: The coverage rate for giving the COVID-19 vaccine to children in several regions of Indonesia is still in the low category, one of which is in Abeli District, Kendari City. One of the factors that can affect the low administration of vaccines
A’yuni, Zera Qurrota, Marhana, Isnin Anang, Supiatun.M, Lilis Sri, Husada, Dominicus   +3 more
core  

Reproductive health for refugees by refugees in Guinea III: maternal health. [PDF]

, 2011
BACKGROUND: Maternal mortality can be particularly high in conflict and chronic emergency settings, partly due to inaccessible maternal care. This paper examines associations of refugee-led health education, formal education, age, and parity on maternal ...
Souare, Yaya, Kollie, Sarah, Borchert, M., David Blankhart, Natasha Howard, Blankhart, David, Woodward, A., Souare, Y., von Roenne, A., Howard, N., Blankhart, D., Kollie, S., Howard, Natasha, von Roenne, Anna, Woodward, Aniek, Anna von Roenne, Aniek Woodward, Matthias Borchert, Yaya Souare, Sarah Kollie, Borchert, Matthias, Howard Natasha, Souare Yaya, von Roenne Anna, Kollie Sarah, Blankhart David, Borchert Matthias, Woodward Aniek   +27 more
core   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito, Kamal Benguerba, Ken Tsuchida, Kazushige Yazawa, Isao Tsumiyama, Hiromitsu Kayama, Sandra P. Reyna, Farid Khan, Richard S. Finkel   +8 more
wiley   +1 more source

Unplanned cesarean sections in advanced maternal age: A predictive model

Acta Obstetricia et Gynecologica Scandinavica
Introduction As maternal age during pregnancy is rising all over the world, there is a growing need for prognostic factors that determine maternal and perinatal outcomes in older women.
Joyce Veenstra, Zoë Cohen, Fleurisca J. Korteweg, David P. van derHam, Simone M. Kuppens, Janna A. Kroese, Brenda B. Hermsen, Marije M. Kamphuis, Joost W. Vanhommerig, Maria G. vanPampus   +9 more
doaj   +1 more source

Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova, Jan Smeitink, Herma Renkema, Rosabeth White, Frankie Barton, Rachel Lyon, Jane Newman, Aye Moe, Yi Shiau Ng, Grainne Siobhan Gorman   +9 more
wiley   +1 more source